To evaluate the early metabolic alterations induced by obesity, we studied glucose turnover and lipid levels in obese children with fasting normoinsulinaemia. Two experimental protocols were carried out. Protocol I consisted of a euglycaemic glucose clamp at two rates of insulin infusion. Protocol II was similar to protocol I except for a variable lipid infusion used to maintain basal non-esterified fatty acid (NEFA) levels. During protocol I, the glucose disappearance rates were lower in obese children, while no differences were found in hepatic glucose release. NEFA response to insulin was not substantially altered in obese children either at low or high insulin infusion. During protocol II, the NEFA clamp induced a 25 % reduction in peripheral insulin sensitivity in control children whereas no changes were observed in obese children. Interestingly, lipid infusion in control children was not sufficient to reproduce the same degree of insulin resistance observed in obese children, suggesting that NEFA are only one of the determinants of insulin resistance at this stage of obesity. In conclusion, the present study provides a portrait of glucose metabolism and lipid levels in normoinsulinaemic obese children. Our results document that peripheral insulin resistance is the first alteration at this stage of obesity, whereas an increase in insulin secretion and a defect in the inhibition of hepatic glucose release by insulin may develop at a later stage. In addition, primarily receptor and post-receptor defects and some alterations of NEFA metabolism are likely to coexist in the induction of insulin resistance at this stage of obesity. [Diabetologia (1995) 38: 739-747] 
Summary
To evaluate the early metabolic alterations induced by obesity, we studied glucose turnover and lipid levels in obese children with fasting normoinsulinaemia. Two experimental protocols were carried out. Protocol I consisted of a euglycaemic glucose clamp at two rates of insulin infusion. Protocol II was similar to protocol I except for a variable lipid infusion used to maintain basal non-esterified fatty acid (NEFA) levels. During protocol I, the glucose disappearance rates were lower in obese children, while no differences were found in hepatic glucose release. NEFA response to insulin was not substantially altered in obese children either at low or high insulin infusion. During protocol II, the NEFA clamp induced a 25 % reduction in peripheral insulin sensitivity in control children whereas no changes were observed in obese children. Interestingly, lipid infusion in control children was not sufficient to reproduce the same degree of insulin resistance observed in obese children, suggesting that NEFA are only one of the determinants of insulin resistance at this stage of obesity. In conclusion, the present study provides a portrait of glucose metabolism and lipid levels in normoinsulinaemic obese children. Our results document that peripheral insulin resistance is the first alteration at this stage of obesity, whereas an increase in insulin secretion and a defect in the inhibition of hepatic glucose release by insulin may develop at a later stage. In addition, primarily receptor and post-receptor defects and some alterations of NEFA metabolism are likely to coexist in the induction of insulin resistance at this stage of obesity. [Diabetologia (1995) 38: 739-747] Key words Obesity, children, insulin action, lipids, glucose turnover.
Obesity in adults has long been associated with multiple disorders of glucose-insulin and lipid homeostasis [1] [2] [3] [4] [5] [6] . In particular, a marked reduction of glucose disposal has been demonstrated in obese subjects reflecting primarily muscle insensitivity to insulin action [7] [8] [9] . In addition, it has been shown that the ira-pairment in insulin action in obese subjects is correlated to an increased non-esterified fatty acid (NEFA) oxidation (glucose-fatty acid cycle) [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . However, since all the previous studies have been performed in patients with marked metabolic alterations related to the long duration of obesity, it remains to be elucidated whether in the early phase of obesity hyperinsulinaemia or a defect in glucose disposal is the first event, and whether NEFA levels play a crucial role in this respect.
Children, at the early onset of obesity and in a phase of rapid weight gain, appear to be an interesting group for studying early alterations in human obesity. However, very few studies have been performed in this group. Bougneres et al. [21] studied seven non-diabetic grossly obese children and found a lower glucose disposal and a higher endogenous glucose produc- [22] have studied obese normoinsulinaemic children and demonstrated an increased lipid oxidation conditioning a decreased glucose oxidation in the fasting period.
In the present study our interests were focused on the evaluation of glucose turnover and lipid levels in a group of obese children with a recent onset of obesity and a rapid weight gain but in the presence of normal insulin levels in the fasting state. The group was compared to age-matched normal weight control children in two protocols. The first protocol (protocol I) consisted of a study on glucose turnover and lipid levels by the euglycaemic hyperinsulinaemic clamp technique at two insulin infusion rates. The second protocol (protocol II) was similar to the first one except for a variable lipid infusion aimed at maintaining NEFA at the basal levels. The NEFA clamp levels permitted assessment of the effect of NEFA levels on glucose turnover at this early stage of obesity.
Subjects and methods
Subjects. Fourteen children with simple obesity (8 males, 6 females) and 13 control children (6 males, 7 females) were studied. Simple obesity was defined as the absence of genetic or endocrinologic abnormalities in the presence of normal stature. Parents freely accepted having their children participate in the study after a full explanation of the aims and the potential side effects or risks. The study was also approved by the Institutional Ethical Review Board.
Anthropometric data and fasting levels. Clinical characteristics and body composition of obese and control children are depicted in Table 1 .
Obese and control children were prepubertal as it is well known that puberty decreases insulin sensitivity [23, 24] . Boys had testes volume less than 4 ml, and pubic hair stage P1. No breast or pubic hair development was seen in girls.
Since we were interested in studying the early stage of obesity, all the obese children chosen had exhibited signs of the L. D. Monti et al.: Insulin action in recent obesity disease for no longer than 6 years with a rapid weight gain in the last year (9.0_+ 2.0 kg). The onset of obesity was dated from when body weight exceeded 120 % ideal body weight using growth curve charts recorded from the children's births. Mean ponderal excess was 59.1 _+ 3.5 % with respect to ideal body weight, according to Tanner and Whitchouse [25] . The evaluation of fat mass was performed with multiple skin-fold measurements (triceps, biceps, subscapular, suprailiac) with a Harpenden caliper [26] by the same trained investigator to reduce the relative inaccuracy of the method [27, 28] . Fat free mass (FFM) was then calculated by subtracting adipose tissue mass from total body weight. The obese children were not dieting before the start of the study and during the period of study all subjects consumed a normo-caloric diet for age and sex according to Italian Dietary Recommendations [29] consisting of 1000 kcal plus 100 kcal per year of age, with 55 % carbohydrate. They all had fasting normoglycaemia and normoinsulinaemia as compared to levels found in control children and to previously reported data [30, 31] and none had a family history of diabetes. Glucose and insulin responses at 120 rain after oral glucose tolerance test (OGTT) were higher in obese than control children (Table 2 ) but all the obese children had normal glucose tolerance according to the criteria of the Diabetes Data Group [32] .
Experirnentalprotocol. The children were admitted to the hospital at 08.00 hours, after an overnight fast. After 30 rain of bed rest and familiarization with the testing procedures and the equipment used, a 20 gauge Abbocath (Venisystems, Abbot Ireland Ltd., Sligo, Republic of Ireland) was inserted in an antecubital vein for intravenous infusions. A similar cannula was retrogradely inserted into a vein of the dorsum of the hand and the hand placed into a plexiglass box heated at 55 ~ for arterialising blood. The sampling cannula was kept patent by a slow 0.9 % NaC1 infusion.
Studies consisted of euglycaemic glucose clamps at either a low insulin infusion rate (0.4 mU. kg -1 . rain 1) or at a high insulin infusion rate (1.7 mU. kg -1 . rain -1) and each obese or control subject was randomly allocated to only one insulin infusion rate for ethical reasons. The studies were performed as paired tests: e.g. one experiment with insulin infusion (protocol I) and a second experiment with insulin plus lipid infusion (protocol II). The order of the two experiments was randoraised, and the two tests were performed one week apart. Except for the lipid infusion, all test procedures were identical for protocol I and II.
Each study began with a primed (5 mg/kg), continuous (0.05 rag. kg 1 9 rain -1) infusion of [6, 6-2H2]-glucose that continued until the end of the study. After a 2-h tracer equilibration period, samples were drawn at -20, -15, -10, -5, -1 rain for subsequent determination of basal glucose turnover. At 0 rain, a 3-h euglycaemic, hyperinsulinaemic clamp at either low or high insulin infusion was begun. After initiation of the insulin infusion, glucose concentration was clamped at the basal level using a variable 20 % dextrose infusion. [6, 6-2H2]-glucose was added to the infused glucose in order to minimize the changes in atom percent excess (APE) during the experiment (hot-GINF technique) [33] . Enrichment of exogenous glucose infusate was calculated by providing estimates of hepatic glucose release (HGR) at basal steady state and of both hepatic glucose release and exogenous glucose infusion rate at the end of the clamp as suggested by Finegood et al. [33] . The enrichment of the infusate was kept constant throughout both insulin infusions and was a compromise between the calculated value for each clamp study. In protocol II, a variable infusion of Intralipid 20 % (Kabivitrum AB, Stockolm, Sweden) was used to clamp NEFA concentration to the level measured in [39] . Serum insulin, C-peptide and glucagon were determined by specific radio-immunoassays. In particular, insulin with Insulin I125 Ria kit (Incstar Corporation, Stillwater, Minn., USA); Cpeptide with C-peptide Double Antibody kit (Diagnostic Products Corporation, Los Angeles, Calif., USA) and glucagon with Ria Mat Glucagon kit (Byk Gulden, Milan, Italy). In our laboratory the intra-assay coefficients of variation (CVs) for the above determinations were 3, 3 and 5 % while inter-assay CVs were 5, 5 and 7 %.
NEFA levels were assayed using an enzymatic technique on Cobas Fara Centrifugal Analyzer (Cobas Fara II, Roche) [40] .
Blood/3-OH-butyrate and glycerol levels were measured on blood deproteinised with 5 % percloric acid using enzymatic spectrofluorimetric techniques [41] . The intra-assay CVs for the above determinations were 2.9 and 5.2 %, respectively, while inter-assay CVs were 4.0 and 5.8 %, respectively. obese children during the fasting period. The lipid infusion was changed every 15-20 min on the basis of NEFA levels determined by Cobas Fara II (Roche, Basel, Switzerland).
Calculation of glucose turnover. The rates of appearance (Ra) and disappearance (Ra) of glucose were calculated using Steele's model [34] by using the stable isotope equivalent of specific activity, i. e. the tracer-to-tracee ratio. Tracer-to-tracee ratio was calculated from APE using the kinetic formalism developed perviously [35] . A pool fraction of 0.65 and a total distribution volume of 260 ml/kg were used. HGR was calculated by subtracting from R~ the exogenous dextrose infusion. Glucose and APE values were subjected to smoothing using the optimal segments technique [36] .
Insulin dose-response curves for R d and HGR.
Insulin dose-response characteristics for stimulation of R d and suppression of HGR were generated by plotting the rates of R d and hepatic release calculated in the last 30 rain of each insulin infusion vs insulin concentration. Since R d reflects the effect of insulin on glucose-utilizing tissues, whereas HGR is mainly regulated by insulin and liver insulin sensitivity, we chose to express R d as the disappearance rate per unit of lean body mass per unit of time (mg. kgFFM i. rain-l) and HGR as the total amount of glucose produced per rain (mg/min).
Calculation of insulin effect on NEFA levels. In order to characterize the dynamics of insulin action on NEFA levels during protocol I, each individual NEFA decay curve was modelled as a delayed exponential decay from an initial level, NEFAi, to a plateau level, NEFAp, as previously described [37] taking into account the time constant of NEFA decay (k), and the time delay (in minutes) between the start of insulin infusion and the beginning of NEFA decrease (At). Parameters NEFAi, NEFAp, k, and At were estimated by non-linear leastsquares technique [38] . The absolute decrements in NEFA levels due to insulin infusion were calculated as NEFAi-NEFA p while the percentage inhibition of NEFA levels due to insulin
Statistical analysis
All data are presented as mean _+ SEM. Comparisons between obese and control children were made by means of analysis of variance followed by Scheffe F-test when appropriate. Comparisons between protocol I vs protocol II were performed within each of the obese and control groups by using paired ttest.
Results
Fasting period. No significant differences were found between the fasting periods of protocols I and II in either group. Obese children were normoglycaemic and normoinsulinaemic as compared to control children. Plasma glucagon, plasma NEFA and serum triglyceride levels were not significantly different in the two groups (Table 2 and 3 ). Blood/3-OH-butyrate levels were higher in obese than control children.
The basal R a was significantly lower in obese children when compared to control children (3.2 + 0.2 vs 4.3 _+ 0.2 rag. kgFFM -1 -min-1; p < 0.05). By contrast, basal HGR was similar in obese and control children (136.2 + 5.4 vs 144.7 _+ 6.3 mg/min, NS).
Clamp period. No significant differences were demonstrated in the plasma glucose levels of obese or control children with either low or high insulin infusion rates during protocol I and II. The coefficients of variation of glucose concentration were always below 5 %. Peripheral insulin levels were slightly higher in obese children than control children both during the low and high insulin infusion rates but the differ- Mean _+ SEM ences failed to reach a statistical significance. Lipid infusion did not cause significant changes in the final steady-state insulin, C-peptide and glucagon levels ( Table 4) . Percentages of inhibition of C-peptide secretion were significantly lower in control children after lipid infusion at high insulin infusion (28.2 + 21.9 vs 54.8 + 7.9 % protocol II vs protocol I; p < 0.01). Figure 1 shows plasma tracer enrichment (APE) at basal (from -20 to 0 rain) and final (from 150 to 180 rain) steady-state during protocols I and II. In the fasting period before the low and high insulin infusion clamp, APE levels were 2.65+0.13 and 2.48 + 0.18 in the obese children and 1.65 + 0.15 and 1.62 + 0.11 in the control children. These levels were maintained virtually constant during the clamp period in all the groups studied. Only in control children at low insulin infusion the APE levels measured at the end of the clamp period were slightly but not significantly higher than during the fasting period. During protocol II the APE levels were superimposable on those obtained during protocol I. Figure 2 (upper panels), suggest that a peripheral insulin resistance is present in obese children. During protocol I, R d values were reduced in obese children by 30% (4.5+0.3 vs 6.2 + 0.5 rag. kgFFM -1 -rain-l; p < 0.05) and 42 % (8.0 + 0.8 vs 13.6 + 1.12 mg 9 kgFFM -1 9 rain 1; p < 0.002) at low and high insulin infusions, respectively. Figure 2 (lower panels), suggest that insulin action on HGR is not impaired in obese children. During protocol I, no significant differences in the percentage of inhibition of HGR were observed between obese and control children (67 vs 80 % at low insulin infusion; NS; and 97 vs 99 % at high insulin infusion; NS). Interestingly, even if HGR was slightly higher in obese children at low insulin infusion, the differences never reached a statistical significance as compared to obese and control children at high insulin infusion. During protocol II, similar inhibitions of HGR were achieved in obese and control children at low and high insulin infusions (39 vs 41%; NS; and 65 vs 59%; NS, respectively). HGR levels were higher in all groups during protocol II as compared to protocol I reaching a significant difference only in control children at low insulin infusion.
Glucose disappearance. The dose-response curves of R d, as reported in

Hepatic glucose release. The dose-response curves of HGR, as reported in
Insulin effect on NEFA levels. Figure 3 shows the NEFA profiles during the two protocols. The data of protocol I suggest that NEFA response to insulin is not substantially altered in obese children even if These defects were partially overcome at high insulin levels during which plateau levels were similar and percentages of inhibition were slightly but not significantly lower in obese as compared to control children (75.8 + 4.1 vs 82.9 __+ 1.8 %). However, the absolute decrements in NEFA were similar between obese and control children both at low (0.537 + 0.082 vs 0.555 + 0.057 mmol/1; NS) or high insulin infusion (0.517 + 0.086 vs 0.662 + 0.056 mmol/1; NS). Glycerol and fl-OH-butyrate levels were similar in the obese and control children and values were superimposable at low or high insulin infusion. During protocol II, the NEFA levels were maintained constant by a variable lipid infusion. Values were 0.859 +0.12 and 0.867 _+ 0.1 mmol/1 in obese and control children at low insulin infusion, and 0.883 + 0.109 and 0.952 + 0.082 mmol/1 at high insulin infusion. The lipid infusions needed to clamp the NEFA levels in obese children was about 30 % lower those of control children during both insulin infusions (1.06 + 0.008 vs 1.38 + 0.007 ml/min, p < 0.05 at low insulin infusion; 2.38 _+ 0.008 vs 3.54 + 0.02 ml/ min, p < 0.05 at high insulin infusion). Glycerol and /3-OH-butyrate levels significantly increased as compared to the fasting values. The area under the curve of glycerol levels was slightly but not significantly lower in obese than control children while the area under the curve of/3-OH-butyrate was comparable both during low and high insulin infusion.
Discussion
A point still in debate is whether in simple obesity, hyperinsulinaemia precedes or is preceded by alterations in glucose and lipid metabolism that are usually found in obese subjects. Previous studies [7, 8, 21, 42, 43] failed to give a definite answer since the obese subjects studied were already hyperinsulinaemic in the fasting state. To clarify this issue, we studied glucose turnover and lipid levels in a group of obese children with obesity of recent onset but still in the presence of normal fasting insulin levels. Two experimental protocols were performed in the obese children and in a control group of normal-weight children. Protocol I consisted of a euglycaemic, hyperinsulinaemic clamp at two different insulin levels within the physiological range. Protocol II was similar to the first one except for the use of a variable lipid infusion which allowed us to clamp NEFA at the basal levels.
Our data show that, despite normal fasting insulin levels, peripheral insulin action was impaired in obese children. In the basal steady state, a significant reduction of peripheral glucose utilization was present in obese children. In addition, the insulin dose-response curve of R d derived from protocol I (Fig. 2 , left upper panel) demostrated that obese children suffer from a marked degree of peripheral insulin resistance, reflecting primarily muscle insensitivity to insulin action. These data are consistent with previous studies on obese adults. Bonadonna et al. [7] , using the euglycaemic insulin clamp technique within the physiological range of insulin concentrations, found an impairment in insulin-mediated glucose disposal. A marked reduction of glucose disposal was demonstrated in massively obese subjects by Del Prato et al. [8] both in the fasting state and during a euglycaemic clamp.
In contrast to peripheral insulin action, liver sensitivity to insulin was not altered in our obese children. Basal HGR (expressed as the total glucose output) was similar ira obese and normal subjects. Furthermore, insulin dose-response curves for suppression of HGR did not differ significantly between the two groups ( Fig. 2, left lower panel) . At insulin levels of 150 pmol/1 a similar decrease of hepatic glucose production was observed in obese and control children achieving values not significantly different from those obtained in the two groups at 600 pmol/1. Interestingly, the values obtained in control children are in striking agreement with those obtained by Katz et al. [44] in normal adults, confirming that the human liver, even during childhood, is exquisitely sensitive to insulin. Our finding that hepatic response to insulin action is not appreciably altered in children at an early stage of obesity is consistent with the results of previous studies on rats at an early stage of obesity [45] or in rats with ventromedial hypothalamic lesions [46] . Furthermore, our finding of a normal liver sensitivity in normoinsulinaemic obese children coupled with the observation of an increased HGR in hyperinsulinaemic obese children, as demonstrated by Bougneres et al. [21] , suggests that a defect in the inhibition of hepatic glucose production by insulin develops later in obesity.
The dose-response curves for stimulation of glucose utilization and inhibition of HGR obtained from protocol II provide insight into the effect of NEFA levels on glucose turnover in the obese and control groups. When NEFA levels were clamped at the fasting levels of the obese children in both groups, a significant 25 % reduction in peripheral insulin sensitivity (measured by the ratio between the increments in glucose clearance and insulin level) was demonstrated in control children while no changes were observed in obese children. Our data are similar to previously reported data in control [16, 18, 19 , 471 and obese adults [17] . As in the case of data from Bevilacqua et al. [17] , the lack of decrease of peripheral insulin sensitivity in obese children might be related to an already depressed glucose disposal. In fact, it has been suggested that during an acute intralipid infusion, the degree of inhibition of 745 glucose utilization is related to the overall rate of glucose disposal [48, 49] . Confirming previous reports [50] , lipid infusion determined an increase of HGR, present in all groups, but reaching a statistical significance only in control children at low insulin infusion.
Although fasting NEFA levels were not different between obese and control children,/3-OH-butyrate levels were higher in obese than control children. This might reflect an early resistance of insulin action on hepatic ketogenesis in obese children in keeping with a previously reported direct insulin inhibition of hepatic ketogenesis independent of NEFA supply [51] , and in agreement with early metabolic alterations in obese children [52] .
The time courses of NEFA levels during protocol I suggest that some alterations in the effect of insulin on NEFA turnover, previously reported in obese adults [53] , were present in our obese children. In fact, during protocol I both at low or high insulin the rate of NEFA decay (k) tended to be lower in obese children than in the control group. In addition, the percent decrease in NEFA levels during the low insulin infusion rate (corresponding to an increment of 120 pmol/1 in peripheral insulin) was lower in the obese children (Table 3) . Additional evidence of a decreased insulin action on NEFA turnover in obese children is provided by the fact that during protocol II the lipid infusion needed to clamp NEFA levels in obese children was 30 % of that used in control children at both insulin infusion rates, in keeping with a previous study by Bevilacqua et al. [17] in which similar intralipid infusions produced twofold higher NEFA levels in obese as compared to normal adult subjects. Nevertheless, the fact that a high insulin infusion rate resulted in no differences in the percentage of NEFA inhibition and that the absolute decrements in NEFA levels were similar in the two groups at either insulin infusion suggest that defects in insulin action on NEFA levels in the obese group are modest and in an initial stage.
The intimate mechanism(s) of the reduced insulin action on NEFA levels in obese children cannot be ascertained from our data because NEFA production and utilization fluxes were not directly assessed. Thus, further investigation is needed to clarify whether at this early stage of obesity NEFA oxidation is increased or not. Nevertheless, since in obese children NEFA levels during the clamp remained higher than in control children and it has been extensively demonstrated that NEFA oxidation correlates with plasma NEFA concentration [54] [55] [56] , we speculate that NEFA oxidation may be increased in obese children, which might contribute to insulin resistance. This notion is supported by the presence of an inverse relationship between NEFA levels and peripheral glucose utilization rates during protocol I (r = 0.533; p < 0.004). On the other hand, since the acute intralipid infusion used to clamp basal NEFA levels during protocol II did not cause a further decrease in the peripheral insulin sensitivity of the obese group, it is likely that NEFA are only one of the determinants of insulin resistance in obesity. This is also sustained by the fact that in control children an acute increase in FFA levels during insulin stimulation was not sufficient to reproduce the same degree of insulin resistance as in the obese children. Thus, it is likely that some other factors, probably a combination of receptor and post-receptor defects, are present in the induction of insulin resistance of the obese group, as previously suggested [6, 57] .
In conclusion, the current study provides a portrait of glucose metabolism and lipid levels in obese children with fasting normoinsulinaemia. Our results show that peripheral insulin resistance is the first alteration at this stage of obesity, whereas an increase in insulin secretion and a defect in the inhibition of HGR by insulin may develop at a later stage. Furthermore, primarily receptor and post-receptor defects and some alterations of NEFA metabolism are likely to coexist in the induction of insulin resistance at this stage of obesity.
